Citi Upgrades Medco Health Solutions (MHS) to Buy
Citi upgrades Medco Health Solutions (NYSE: MHS) from Hold to Buy. Price target $57.
Citi analyst says, "Favorable trends include: 1) Recent contract renewal of its most significant customer (UnitedHealth (NYSE: UNH)) making up 22% of 2007 total net revenues, 2) multi-year cycle of drug patent expirations and generic drug launches that are more profitable; 3) rising penetration of mail order pharmacy; 4) leading specialty pharmaceutical franchise Accredo Health; 5) visibility on strong EPS growth of 25%-27% in 2008, and we model ~16% long-term."
Medco Health Solutions Inc. (Medco) is a pharmacy benefit manager. The Company provides traditional and specialty prescription drug benefit programs and services for its clients and members. [SM]
Related Categories
UpgradesStocks Mentioned
Related Entities
Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

UNH
LES on Apr 23, 2008 03:23 AMI am contemplating invest right now in UNH . What do you think about my decission ? I am a newcommer so please do not ridicule me . Thanx, LES